| INTRODUCTION
Diabetes mellitus (DM) is a major risk factor for periodontal diseases and the prevalence of periodontitis is higher in patients with DM than in individuals without DM. 1, 2 Epidemiological studies reported that clinical attachment loss and the risk of alveolar bone loss were greater in patients with uncontrolled DM than in individuals without DM 3, 4 and periodontitis in patients with DM was sometimes associated with severe inflammation and the destruction of periodontal tissues (DMassociated periodontitis). [5] [6] [7] DM induces inflammatory responses in kidney, blood vessels, retina and nerve tissues, and induces serious complications including nephropathy, neuropathy and retinopathy, which exacerbate systemic conditions. 8, 9 Hyperglycemia occurs in DM and strongly induces the glycation of proteins via the non-enzymatic
Maillard reaction, resulting in the production of advanced glycation end-products (AGEs). 10 AGEs bind to the receptor for AGE (RAGE) and increase the expression of proinflammatory cytokines such as interleukin (IL)-1β, IL-6 and tumor necrosis factor-α, enhance oxidative stress activity in some cells, 11 cross-link extracellular matrix (ECM) proteins such as collagen and fibronectin, accumulate on the ECM, and weaken the structure of the ECM and bone. 12 AGEs accumulate in periodontal tissues in greater amounts in patients with DM than in individuals without DM 13 and are present in epithelial cells, fibroblasts, endothelial cells and inflammatory cells in the periodontal tissues of patients with DM. 14 RAGE is also known to be expressed in the gingival tissues of patients with DM, 15 and RAGE mRNA expression in human gingival fibroblasts (HGFs) was previously shown to be increased by AGEs. 16 AGEs inhibit collagen synthesis in HGFs, 17 increase the expression of matrix metalloproteinase 1 (MMP-1) in HGFs, 18 and decrease alkaline phosphatase activity and osteocalcin expression, but increase IL-1β expression in rat osteoblastic cells. 19 These findings suggest that AGEs aggravate inflammation, the destruction of periodontal tissues and bone resorption in DM-associated periodontitis.
IL-6, a proinflammatory cytokine, is expressed in some cells including fibroblasts, epithelial cells, endothelial cells, osteoclasts, lymphocytes and monocytes/macrophages, and influences inflammatory diseases including rheumatoid arthritis and periodontal diseases. 20 IL-6 levels in the gingiva and peripheral blood were previously reported to be significantly higher in patients with periodontitis and type 2 DM than in patients with periodontitis, but without DM. 21, 22 When peripheral blood from patients with periodontitis and type 2 DM was stimulated with Porphyromonas gingivalis lipopolysaccharide (P.g-LPS), IL-6 levels in blood increased more than in that from individuals without DM. 22 Chiu et al 23 32 These findings suggest that ICAM-1 is associated with the pathogenesis of periodontitis and DM.
To elucidate the mechanisms responsible for the DM-induced aggravation of periodontal diseases, we investigated the effects of AGEs on the expression of inflammation-related factors, particularly IL-6 and ICAM-1, in HGFs and also examined the AGE signaling pathway.
| MATERIAL AND METHODS

| Advanced glycation end-products and reagents
AGEs were prepared according to the modified method of Takeuchi et al. 33 Briefly, 50 mg/ml bovine serum albumin (BSA; Sigma-Aldrich, St. Louis, MO, USA) was mixed with dl-glyceraldehyde (0.1 mol/L; Sigma-Aldrich), penicillin (100 U/ml) and streptomycin (100 μg/ml) in a sterile phosphate buffer (0.2 mol/L, pH 7.4) and incubated at 37°C for 7 days. The mixture was dialyzed against phosphate-buffered saline (PBS, pH 7.4) to remove low-molecular-weight reactants and free glyceraldehyde. Non-glycated BSA as a control was prepared from the mixture without glyceraldehyde under the same conditions. AGE activity was assessed by the fluorescence of AGE and non-glycated BSA solutions at excitation/emission wavelengths of 370/440 nm.
Conclusion:
AGEs increase IL-6 and ICAM-1 expression via the RAGE, MAPK and NF-κB pathways in HGFs and may exacerbate the progression of the pathogenesis of periodontal diseases.
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The fluorescence of the AGE solution was 45-fold stronger than that of control non-glycated BSA. 
| Cell culture
| Cell viability assay
After subconfluency, cell proliferation activity was examined using denaturing at 94°C for 1 min, annealing at 55-60°C for 1 min and extension at 72°C for 1 min. PCR products were analyzed by electrophoresis on a 1.5% agarose gel containing 0.1 μg/ml ethidium bromide.
The expression of genes including RAGE, IL6, ICAM1, MCP1, vascular endothelial growth factor (VEGF) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was investigated by RT-PCR. In qRT-PCR, the cDNA of IL-6, ICAM-1 or GAPDH was added to the PCR mixture containing primers (Table 1) and SYBR Green Supermix ® (Bio-Rad).
The reaction was performed at 95°C for 30 seconds once, at 95°C for Real-Time PCR Detection System (Bio-Rad). The relative mRNA levels of IL6 and ICAM1 were normalized to GAPDH mRNA.
| Western blotting
HGFs were cultured with 500 μg/ml BSA or AGEs for 30 minutes and phospho-JNK, p65-and phospho-p65, and IκBα and phospho-IκBα, and with a β-actin rabbit antibody (1/10 000 dilution) at 4°C
overnight, and then reacted with horseradish peroxidase-conjugated goat antirabbit IgG (Cell Signaling) at room temperature for 1.5 hours.
The reacted membrane was developed using ECL Western Blotting Detection Reagents (GE Healthcare Life Sciences) and exposed to
Amersham Hyperfilm ™ ECL (GE Healthcare Life Sciences).
| Enzyme-linked immunosorbent assay
The conditioned medium (supernatant) and cell lysate were collected from the culture of HGFs treated with AGEs or BSA for 48 hours to examine the effects of AGEs on the production of IL-6 and ICAM- 
| Reactive oxygen species measurement
Intracellular ROS levels were measured using the OxiSelect 
| Transfection of receptor for advanced glycation end-products and interleukin-6 siRNAs
HGFs were seeded at 9500 cells/cm 2 
| Cell adhesion assay
THP-1 cells were seeded at 1. 
| Statistical analysis
All statistical analyses were performed with SPSS Statistics version 20 (IBM, Chicago, IL, USA). The significance of differences between 2 groups was analyzed by the Student's t-test. Comparisons of multiple groups were performed using a 1-way analysis of variance followed by
Tukey's HSD. P < .05 was considered significant.
| RESULTS
| Advanced glycation end-products do not affect the cell viability and morphology of human gingival fibroblasts cultured for 72 hours
AGEs (500 μg/ml) did not affect the cell viability of HGFs by 72 hours ( Figure 1A) ; however, cell viability significantly decreased by 96 hours under culture conditions with AGEs (500 µg/ml) and BSA (500 µg/ ml). AGEs did not affect cellular morphology when cells were cultured with AGEs and BSA (500 µg/ml each) for 72 hours ( Figure 1B ). AGEs (500 μg/ml) increased RAGE production in HGFs more than BSA for 24 hours ( Figure 3A) . When HGFs were cultured with AGE (500 μg/ml) and BSA for 48 hours, the production of IL-6 and ICAM-1 was significantly upregulated by approximately 2-fold and 3-fold, respectively ( Figure 3B,C) . Furthermore, AGEs (500 µg/ml) significantly , cultured for 5 days, and then treated with fresh BSA (500 μg/ml; open column) and AGEs (500 μg/ml; closed column) every day for 24-96 h. Cell proliferation activity was assessed using Cell Counting Kit-8 ® . Data are expressed as the mean ± SD of 3 independent experiments (**P < .01). (B) Cultured HGFs were observed by phase-contrast microscopy after a culture with or without BSA (500 μg/ml) and AGEs (500 μg/ml) for 72 h. (Magnification × 40). AGEs, advanced glycation end-products; BSA, bovine serum albumin; Cont., control; HGFs, human gingival fibroblasts F I G U R E 2 Effects of AGEs on the gene expression of RAGE and inflammation-related factors in HGFs. (A) Subconfluent HGFs were cultured with BSA (500 μg/ml) and AGEs (500 μg/ml) for 24, 48 and 72 h. Isolated RNAs were analyzed by RT-PCR using specific primers for RAGE, IL6, ICAM1, MCP1, VEGF and GAPDH (Table 1) . (B) RNA samples were isolated from HGFs treated with BSA (0-1000 μg/ml; open column) and AGEs (50-1000 μg/ml; closed column) for 48 h and IL6 mRNA expression was analyzed by qRT-PCR. (C) ICAM1 mRNA expression in HGFs treated with BSA (500 μg/ml; open column) and AGEs (500 μg/ml; closed column) for 48 h was assessed by qRT-PCR. mRNA expression was normalized to that of GAPDH. Data are expressed as the mean ± SD of 3 independent experiments (*P < .05, **P < .01). AGEs, advanced glycation end-products; BSA, bovine serum albumin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HGFs, human gingival fibroblasts; ICAM-1, intercellular adhesion molecule-1; qRT-PCR, quantitative real-time polymerase chain reaction; RAGE, receptor of advanced glycation end-products; VEGF, vascular endothelial growth factor increased ROS activity in HGFs at 6 hours in a time-dependent manner, and this activity was approximately 3-fold that of the control at 72 hours ( Figure 3D ).
| Advanced glycation end-products increase
| Interleukin (IL)-6 increases intercellular adhesion molecule (ICAM)-1 expression and receptor of advanced glycation end-products and IL-6 siRNAs inhibit advanced glycation end-product-induced IL6 and ICAM1 expression in human gingival fibroblasts
To investigate the mechanisms underlying AGE-induced IL-6 and ICAM-1 expression, HGFs were cultured with rhIL-6 (50 ng/ml) for 24 hours (qRT-PCR) and 48 hours (ELISA). rhIL-6 significantly increased the mRNA expression of ICAM1 by 1.9-fold that of the control ( Figure 4A ) and the expression of ICAM-1 protein by approximately 3-fold (rhIL-6: 1.58 ng/mg total protein) that of the control (0.52 ng/mg total protein) ( Figure 4B ).
When HGFs were cultured with RAGE siRNA and then with AGEs, RAGE mRNA expression was inhibited ( Figure 4C ) and AGE-induced IL6 and ICAM1 expression was significantly decreased by the knockdown of RAGE (Figure 4D,E) . IL-6 siRNA downregulated the expression of IL6 in HGFs stimulated by AGEs and BSA ( Figure 4F ) and significantly decreased AGE-induced ICAM1 expression to lower levels than that induced by BSA ( Figure 4G ).
| Advanced glycation end-products upregulate interleukin-6 and intercellular adhesion molecule-1 expression via MAPK and nuclear factor-κB pathways
The involvement of the MAPK pathway in AGE-induced IL-6 and ICAM-1 expression were investigated. When HGFs were stimulated by AGEs, the phosphorylation of p38 and ERK MAPK in cells was enhanced by AGEs, whereas that of JNK was not ( Figure 5A ).
AGEs increased the expression of IL6 mRNA and the IL-6 protein in HGFs, and a p38 inhibitor (SB203580) and ERK inhibitor Figure 7C ).
F I G U R E 3 Effects of AGEs on the productions of RAGE, IL-6
and ICAM-1 and ROS activity in HGFs. (A) Subconfluent HGFs were treated with BSA (500 μg/ml) and AGEs (500 μg/ml) for 24 h. Cell lysates were analyzed by western blotting using a RAGE antibody as described in the Material and methods. Results obtained show a representative of 3 independent experiments. (B,C) Subconfluent HGFs were treated with BSA (500 μg/ml; open column) and AGEs (500 μg/ml; closed column) for 48 h. Amounts of IL-6 (B) in the supernatant and ICAM-1 (C) in the cell lysate were measured using each enzyme-linked immunosorbent assay as described in the Material and methods. Production of ICAM-1 was normalized to the total cell protein amount. (D) ROS activity in HGFs treated with BSA (500 μg/ml; open diamond) and AGEs (500 μg/ml; closed square) for 6-72 h was assessed using a ROS activity assay kit. Data are expressed as the mean ± SD of 3 independent experiments (**P < .01). AGEs, advanced glycation end-products; BSA, bovine serum albumin; Cont., control; HGFs, human gingival fibroblasts; ICAM-1, intercellular adhesion molecule-1; IL, interleukin; RAGE, receptor of advanced glycation end-products; ROS, reactive oxygen species
| DISCUSSION
AGEs induce increases in inflammation and upregulation of tissue degradation in patients with DM resulting in end-organ complications such as microvascular diseases, nephropathy, neuropathy and retinopathy. 8 AGEs increase the expression of proinflammatory cytokines such as IL-1β, IL-6 and tumor necrosis factor-α in some tissues 11 and inhibit collagen synthesis in gingival fibroblasts. 17 Sakamoto et al 19 reported that AGEs increased IL-1β expression and decreased bone nodule formation, alkaline phosphatase activity and osteocalcin production in osteoblastic cells from rat bone marrow. AGEs and P.g-LPS exposure further increased IL-1β expression in osteoblastic cells. 19 AGEs and the pathogens of periodontitis are considered to aggravate inflammation and degrade periodontal tissues in patients with periodontitis and DM.
IL-6 levels were previously reported to be high in the periodontal tissues and gingival crevicular fluid of patients with periodontitis. 34, 35 IL-1β and IL-6 levels in periodontal tissues were higher in patients with periodontitis and DM than in those with periodontitis, but not DM. 21 IL-6 promotes the progression of periodontitis by inducing the expressions of proMMP-1, VEGF and cathepsins in HGFs 36 and MMP-1 in human macrophages 37 as well as osteoclast formation. 38 Sundararaji et al 37 reported that a high glucose concentration (25 mmol/L) increased IL-6 secretion from HGFs, and IL-6 levels from HGFs cultured in medium with high glucose concentrations and LPS were higher than those in medium with high glucose concentrations, but no LPS. AGEs are known to accumulate at greater amounts in the gingival tissues of patients with DM than in those of individuals without DM. 13 The combination of high glucose concentrations and AGEs more strongly upregulated IL-6 production, while the combination of AGEs and P.g-LPS under high glucose conditions synergistically increased IL-8 expression in HGFs. 23 In the present study, AGEs increased IL-6 expression in
HGFs and promoted the production of IL-6 and ROS activity in combination with P.g-LPS (data not shown). In addition, the combination of AGEs and P.g-LPS further increased the expression of inflammationrelated factors and inhibited the differentiation of osteoblastic cells. 19 These findings suggest that high glucose concentrations and AGEs induce inflammation in periodontal tissues by upregulating IL-1β, IL-6
and IL-8 expression in DM, and the combination of P.g-LPS, hyperglycemia and AGEs may induce severe DM-associated periodontitis.
ICAM-1 influences the conditions of periodontitis and DM
through its functions such as intercellular adhesion, migration and
Effects of rhIL-6 on ICAM-1 expression and inhibitory effects of RAGE and IL-6 siRNAs on AGE-induced IL6 and ICAM1 mRNA expression in HGFs. Subconfluent HGFs were treated with rhIL-6 (50 ng/ml) for 24 and 48 h. (A) RNA was isolated from the treated cells and the mRNA expression of ICAM1 was assayed by qRT-PCR. mRNA expressions of ICAM1 were normalized to that of GAPDH. (B) Amount of ICAM-1 in the lysate of treated cells was measured using enzyme-linked immunosorbent assay as described in the Material and methods. Production of ICAM-1 was normalized to the total cell protein concentration. HGFs were seeded at 9500 cells/ cm 2 , cultured for 1 d, reached 70% confluency, and then treated with control siRNA (siCont.; 10 μmol/L), RAGE siRNA (siRAGE; 10 μmol/L), or IL-6 siRNA (siIL6; 10 μmol/L) for 24 h as described in the Material and methods. HGFs were cultured further with BSA (500 μg/ml; open column) and AGEs (500 μg/ml; closed column) for 48 h. RNA samples in cells transfected with each siRNA were isolated, the expression of RAGE mRNA was analyzed by RT-PCR (C), and the mRNA expression of IL6 (D and F) and ICAM1 (E and G) was assessed by qRT-PCR. mRNA expression of IL6 and ICAM1 was normalized to that of GAPDH. Data are expressed as the mean ± SD of 3 independent experiments (*P < .05, **P < .01). AGEs, advanced glycation endproducts; BSA, bovine serum albumin; Cont., control; GAPDH, and ICAM-1 in the cell lysate (E) were measured using each enzyme-linked immunosorbent assay kit. Data are expressed as the mean ± SD of 3 independent experiments (*P < .05, **P < .01). AGEs, advanced glycation end-products; BSA, bovine serum albumin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HGFs, human gingival fibroblasts; ICAM-1, intercellular adhesion molecule-1; IL, interleukin F I G U R E 6 Effects of the NF-κB inhibitor on AGE-induced IL-6 and ICAM-1 expression and phosphorylation of p65 and IkBα in HGFs. (A) Subconfluent HGFs were treated with 500 μg/ ml BSA and AGEs for 30 min, and the cell lysate was collected. NF-κB phosphorylation was analyzed by western blotting using antibodies against p65, phospho-p65, IκBα, and phospho-IκBα. (B-E) Subconfluent HGFs were pretreated with an IKK inhibitor; Bay11-7082 (50 μmol/L) for 24 h and then cultured with BSA (500 μg/ml; open column) and AGEs (500 μg/ml; closed column) for 24 h. RNA samples were isolated from the treated cells and the mRNA expression of IL6 (B) and ICAM1 (C) was measured by quantitative real-time polymerase chain reaction. mRNA expression of IL6 and ICAM1 was normalized to that of GAPDH. Supernatant and cell lysate were prepared from HGFs pre-cultured with Bay11-7082 (50 μmol/L) for 24 h and then cultured with BSA (500 μg/ml; open column) and AGEs (500 μg/ml; closed column) for 48 h, and the amounts of IL-6 in the supernatant (D) and ICAM-1 in the cell lysates (E) were measured using each enzyme-linked immunosorbent assay kit. Data are expressed as the mean ± SD of 3 independent experiments (*P < .05, **P < .01). AGEs, advanced glycation endproducts; BSA, bovine serum albumin; GAPDH, In the present study, AGEs increased the levels of ROS as well as IL-6 and ICAM-1 in HGFs. ROS damaged periodontal tissues by degrading ECM proteins, inducing alveolar bone loss and aggravating periodontal tissue destruction in periodontitis. 43, 44 AGEs increased plasminogen activator inhibitor-1 levels via ROS and the ERK and NF-κB pathways in human glomerular mesangial cells, 45 upregulated RAGE protein and intracellular ROS levels through ERK activation, induced mitogenesis in renal fibroblasts 46 and, consequently, influenced the pathogenesis of diabetic nephropathy. We speculate that AGEs exacerbate the progression of DM-associated periodontitis by stimulating inflammatory cytokines and ROS in gingival fibroblasts.
AGEs bind to RAGE on endothelial cells, epithelial cells and fibroblasts in periodontal tissues, 15, 16 and RAGE is strongly expressed in the gingiva of patients with DM and periodontitis. 47 AGEs induced MMP-1 expression via RAGE and NF-κB in fibroblasts isolated from human gingival tissues, 18 and increased IL-6, MCP-1 and VCAM-1 expression and stimulated migration capacity via the ERK, JNK, p38
MAPK and NF-κB pathways in adventitial fibroblasts. 48 were labeled with a fluorescent reagent and co-cultured with HGFs transfected with IL-6 siRNA (10 μmol/L) for 30 min, and fluorescence intensity was determined using a fluorescence microplate reader. Cell adhesive activity was normalized to that of HGFs treated with BSA (BSA cont.). Data are expressed as the mean ± SD of 4 independent cell samples (*P < .05, **P < .01). AGEs, advanced glycation endproducts; BSA, bovine serum albumin; Cont., control; HGFs, human gingival fibroblasts; IL, interleukin
